Dr. Paul Adams joins La Jolla Pharmaceutical advisory board

La Jolla Pharmaceutical Company has named four physicians to its LJPC-401 advisory board, including gastroenterologist Paul Adams, MD.  

Advertisement

The LJPC-401 advisory board focuses on the company’s development of hepcidin. Dr. Adams is a professor of medicine and chief of gastroenterology at the University of Western Ontario in London, Ontario. The company also added:

•    Victor Gordeuk, MD
•    Ashutosh Lal, MD
•    Gordon McLaren, MD

More articles on gastroenterology:
Mutare Health names Dr. Lawrence Kosinski CMO
Ritter Pharmaceuticals names Gerald Proehl to board of directors
PPI therapy may increase risk of kidney injury in elderly

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.